Rare diseases
Investigational molecules
Locations
Back to Austria17 clinical trials in Leoben, Austria. Every trial is listed in the EU Clinical Trials Register and updated daily.
A Phase 3 Study of Sapablursen Compared with Placebo in Adults with Polycythemia Vera
AustriaHigh-Dose Colecalciferol for 28-Day Mortality in Critically Ill Adults with Severe Vitamin D Deficiency
AustriaA study comparing odronextamab combined with chemotherapy versus rituximab combined with chemotherapy in adults with previously untreated follicular lymphoma
AustriaStudy of Revumenib and Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia with NPM1 Gene Mutation
AustriaStudy on Letrozole Maintenance Therapy for Patients with Epithelial Ovarian Cancer
AustriaStudy on Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis and Suboptimal Response to Ruxolitinib
AustriaStudy Comparing Mezigdomide, Bortezomib, and Dexamethasone with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma
AustriaStudy of Teclistamab and Lenalidomide as Maintenance Treatment for Newly Diagnosed Multiple Myeloma Patients After Stem Cell Transplantation
AustriaStudy on Venetoclax and Obinutuzumab for Adults with Recurring Chronic Lymphocytic Leukemia
AustriaStudy on the Effects of Carboplatin and Cisplatin in Patients with Early-Stage, Intermediate-Risk Cervical Cancer
AustriaStudy Comparing Elacestrant and Standard Endocrine Therapy for Patients with Early Breast Cancer at High Risk of Recurrence
AustriaStudy on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer
AustriaThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on hormone receptor-positive breast cancer treatments, including studies of novel therapies for patients with high-risk disease profiles.
Multiple studies evaluating innovative therapeutic approaches for improving patient outcomes in early and advanced stages.
Comprehensive research into various types of lymphoma, examining new treatment combinations and comparing their effectiveness to standard therapies.
Investigations focus on improving treatment responses while minimizing side effects.
Innovative trials exploring multiple myeloma treatments, including maintenance therapy approaches and combination treatments for both newly diagnosed and relapsed cases.
Studies aimed at improving treatment outcomes for various stages of the disease.
Research focusing on chronic lymphocytic leukemia and related blood disorders, evaluating novel therapeutic combinations.
Trials designed to improve treatment outcomes for patients with recurring disease.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
